Business Context and Reporting Period
This Form 6-K filing by James Hardie Industries plc covers the month of March 2022, with the report signed on March 25, 2022. The company is a foreign private issuer headquartered in Dublin, Ireland, and files annual reports on Form 20-F.
Key Financial Metrics
The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing does not disclose specific material changes in financial performance or operations compared to prior periods. The document primarily serves to disclose forward-looking statements and list exhibits regarding corporate actions.
Guidance, Outlook, and Risks
The filing contains extensive forward-looking statements regarding future performance, capital expenditure projects, credit facilities, dividend payments, and share buy-backs. Key risks and contingencies identified include:
- Liabilities related to the prior manufacture of asbestos-containing products and contributions to the Asbestos Injury Compensation Fund (AICF).
- Legal proceedings, including product liability, environmental, and consumer class actions.
- Impact of the COVID-19 public health crisis on sales and operations.
- Dependence on residential and commercial construction markets and housing affordability.
- Currency exchange rate fluctuations and raw material costs.
- Uncertainty regarding the discontinuance of LIBOR.
Exhibits included in this filing relate to future capacity expansion plans in Australia, an application for security quotation, and the resignation of a director.
Investor Verification Checklist
- Verify the specific financial results for the period ending March 25, 2022, in the company's most recent Form 20-F or earnings release, as this 6-K does not contain them.
- Review the details of the "JHX Plans for Future Capacity Expansion in Australia" (Exhibit 99.1) for capital expenditure implications.
- Confirm the identity and reason for the resignation of the director mentioned in Exhibit 99.3.
- Monitor updates on asbestos-related liabilities and AICF funding requirements.